Latest Breaking News On - Molecular tests - Page 2 : comparemela.com

The Impact Of The Rise In Chronic Disease Incidence On The Blood And Blood Components Market

The Impact Of The Rise In Chronic Disease Incidence On The Blood And Blood Components Market
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomCity ofGreater londonUnited kingdom generalBrentuximab vedotinAsia pacificRituaxan mabtheraGleevac glivecBlood group typing global marketProperties testingDrug administrationCanadian blood servicesUnited nationsSurgical centersMarket research products

CStone Pharmaceuticals Reports 2022 Interim Results and Business Updates

SUZHOU, China, Aug. 25, 2022 /PRNewswire/ CStone Pharmaceuticals Reports 2022 Interim Results and Business Updates

United statesHong kongWei liFrank ningjun jiangJianxin yangJosephl goldsteinMichaels brownNational pathology quality control centerXianning branch of hubei medical collegeResearch developmentStock exchangeChinese medical doctor associationAmerican society of clinical oncology annual meetingCstone global industrializationSenior advisor of the companyCstone pharmaceuticals the company

Global Lung Cancer Diagnostics Market to Reach $3 7 Billion

Abstract: What’s New for 2022? -Global competitiveness and key competitor percentage market shares. .

New yorkUnited statesUnited kingdomSouth koreaLal pathlabsResearch initiatives in lung cancerPlexbio co ltdEffervescent rate of new innovations product developmentCore laboratoryWorld historic review for cancer research institutesAge group in millionNeogenomics laboratories incGenetics incMarketglass research platformThermo fisher scientific incIllumina inc

CStone Pharmaceuticals Reports 2021 Annual Results and Recent Business Highlights

SUZHOU, China, June 1, 2022 /PRNewswire/ CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today reported 2021 full-year financial results and recent business highlights. Dr. Frank Jiang, CEO of CStone, commented, "As a full-fledged biopharmaceutical company, we achieved significant milestones in 2021. As of.

United statesHong kongFrank jiangNational pathology quality control centerAmerican society for clinical oncologyResearch developmentChinese medical doctor associationHong kong department of health hk doChinese medical association guidelinesChina national medical products administrationEuropean unionJiangsu hengrui pharmaceuticals co ltdYuanxin technology group co ltdChinese society of clinical oncologyInternational financial reporting standardsCancer association

Researchers Develop a Hybrid Alternative for Instant Detection of SARS-Cov-2

Researchers have presented a unique portable flow-virometry reader (FVR) for rapid identification of SARS-CoV-2 directly from saliva samples, which blends the quick turnaround time of an antigen test with a high sensitivity comparable to RT-PCR.

United statesUnited kingdomCohenk leshemLaura thomsonLaura thomsonmarShrivastavaa guptaAmerican centerEuropean commissionTime diagnostic panelJournal of the chinese medical associationJohns hopkins centerLaboratory medicineHamamatsu photonicsHealth securityCorona borealisBiomedical optics